Sabby Management’s Kezar Life Sciences KZR Stock Holding History

Sabby Management’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-4,251	Closed	-$735K	–	138
2018 Q2	$735K	Buy	+4,251	New	+$742K	0.11%	71

Other funds holding KZR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Sabby Management's KZR Position: Q3 2018 in Review

Sabby Management sold out of Kezar Life Sciences (KZR) in Q3 2018, closing a stake of 4,251 shares — an estimated $735K sold.

Sabby Management first reported a position in KZR in Q2 2018 and held it in 1 quarter. The position peaked at $735K in Q2 2018. 37 funds tracked by Wall St. Rank hold KZR as of Q3 2018.

Sabby Management reported no remaining Kezar Life Sciences position as of Q3 2018 after selling out during the quarter.
Sabby Management sold 4,251 Kezar Life Sciences shares in Q3 2018, an estimated $735K.
Sabby Management first reported a position in Kezar Life Sciences in Q2 2018 and held it in 1 quarter.
Sabby Management's Kezar Life Sciences position peaked at $735K in Q2 2018.
37 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q3 2018.

Based on Sabby Management's 13F filing for Q3 2018, filed 14 Nov 2018.